Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;23(2):125-31.
doi: 10.5021/ad.2011.23.2.125. Epub 2011 May 27.

Epithelial tumor, invasion and stroma

Affiliations

Epithelial tumor, invasion and stroma

Masutaka Furue. Ann Dermatol. 2011 May.

Abstract

Uncontrolled proliferation is a defining feature of the malignant phenotype. Nevertheless, the supportive network provided by the stroma is indispensable for further invasion, progression and metastasis of cancer cells. In addition, the role of inflammation in tumorigenesis is now generally accepted, and it has become evident that an inflammatory microenvironment is an essential component of tumor progression. Since skin tumors are common and easily assessable lesions with features at various stages of tumorigenesis, they provide a wide scope for research in this field to further our understanding of fundamental and clinical carcinogenesis. Some of the basic aspects of epithelial tumorigenesis, invasion and stromal reaction are reviewed in this paper.

Keywords: Fibroblast; Invasion; Stroma; Tumor.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Process of epithelial-mesenchymal transition (EMT).
Fig. 2
Fig. 2
Inducers of type 3 epithelial-mesenchymal transition (EMT), carcinoma-metastatic transition.
Fig. 3
Fig. 3
Markers of epithelial-mesenchymal transition (EMT).
Fig. 4
Fig. 4
TGF-β signaling and epithelial-mesenchymal transition (EMT).
Fig. 5
Fig. 5
Integrin signaling.
Fig. 6
Fig. 6
Intracellular signaling by hypoxia and stromal reaction.

References

    1. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004;5:816–826. - PubMed
    1. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12:895–904. - PubMed
    1. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119:1429–1437. - PMC - PubMed
    1. Miyazono K. Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85:314–323. - PMC - PubMed
    1. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–890. - PubMed